Aging Population Drives Healthy Prescription Dermatological Drug Growth Market Set to Reach $11.1 Billion by 2010

New York, February 16, 2006 — The aging of the worldwide population and a focus on lifestyle treatments that revitalize youthfulness and stave off skin damage are the driving forces behind a healthy prescription dermatological drug market, which should see sales jump to $11.1 billion by 2010, according to a new study from market research firm Kalorama Information, a division of MarketResearch.com, the leading provider of industry-specific market research reports.

With 2005 sales reaching $8.4 billion, The Worldwide Market for Prescription Dermatological Drugs predicts that sales in the antiaging, photodamage, hair treatment, psoriasis, and skin cancer segments will grow further at a rate of 5.7% over the next four years as consumer demand for newer and better derma drugs continues to increase as the aging population struggles to deal with a myriad of skin disorders and diseases.

While sales of prescription acne, Rosacea, dermatitis, seborrhea, and hyperpigmentation/melasma products have continued to perform well—although with slower growth rates during the last five years as many of these drugs are older or have lost patent protection—the overall market has been bolstered by recent trends in cosmeceuticals, a favorite among aging Baby Boomers.

“The aging population is better educated and wants to see results—whether they have wrinkles, skin cancer, or psoriasis. Today’s consumers are savvy to innovative dermatological treatments, derma drug delivery developments, and new prescription drug information which is widely available on the internet,” notes Mary Anne Crandall, RN, the author of the final report. “This has changed the face of dermatology as cosmetic dermatology is now in vogue and manufacturers are racing to find new treatments to satiate public demand.”

This 5th Edition of The Worldwide Market for Prescription Dermatological Drugs completely re-evaluates the global prescription dermatological drug market from the ground up and includes a comprehensive look at a variety of skin disorders with a focus on market share, key trends and innovations, demographics, epidemiology, and geographic breakdowns. It can be purchased directly from Kalorama Information by clicking http://www.kaloramainformation.com/pub/1186397.html. It is also available at MarketResearch.com.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information visit www.KaloramaInformation.com or contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com.